Sign In
Buy ROIV
$31.25
-0.180 (-0.573%)
At Close: Jun 22, 2026
Market Today: Nvidia beats, Meta chip deals, Amex HQ move
05:37pm, Wednesday, 25'th Feb 2026
Guru Stock PicksDavid Herro has made the following transactions:Reduce in CNH by 1.5%Sold out in XAMS:EXOAdd in TSE:6273 by 1.02%New position in LSE:ULVROakmark
First Look: Nvidia in Focus, WBD Bid Drama, AMD--Meta Deal
07:38am, Wednesday, 25'th Feb 2026
Stock News Nvidia's big test: Nvidia (NVDA) reports after the bell with options implying a 5.6% move â the smallest expected postâearnings swing in at least
Market Today: AMD--Meta AI pact, WBD bid war, Stripe at $159B
05:35pm, Tuesday, 24'th Feb 2026
Guru Stock PicksPaul Singer has made the following transactions:Reduce in LUV by 8.86%Stock News Meta taps AMD for AI buildout: Meta Platforms (META) signed a m
First Look: Gilead buys Arcellx; IBM sinks on AI; Bitcoin slides
07:37am, Tuesday, 24'th Feb 2026
Stock News Dimon warns on credit cycle: JPMorgan Chase (JPM) CEO Jamie Dimon cautioned that elevated asset prices and growing banking competition echo preâ200
Eric Venker Sells 200,000 Shares of Roivant Sciences (NASDAQ:ROIV) Stock
04:56am, Friday, 20'th Feb 2026
Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the firm's stock in a transaction on Friday, February 13th. The stock was sold at an average price of $26.
Jefferies Group Exits Vanguard Information Technology ETF, Impacting Portfolio by -8.06%
01:00pm, Monday, 09'th Feb 2026
Jefferies Group (Trades, Portfolio)'s Strategic Moves in Q4 2025: A Detailed Analysis Jefferies Group (Trades, Portfolio) recently submitted its 13F filing for
Roivant Sciences Ltd. $ROIV Shares Bought by New York State Common Retirement Fund
04:04am, Sunday, 08'th Feb 2026
New York State Common Retirement Fund lifted its stake in shares of Roivant Sciences Ltd. (NASDAQ: ROIV) by 25.4% during the third quarter, according to its most recent disclosure with the Securities
Roivant Sciences (NASDAQ:ROIV) Sets New 1-Year High – What’s Next?
02:48am, Sunday, 08'th Feb 2026
Roivant Sciences Ltd. (NASDAQ: ROIV - Get Free Report)'s stock price hit a new 52-week high on Friday. The stock traded as high as $25.49 and last traded at $24.7320, with a volume of 3598048 shares.
Roivant: The Next Telavant Has Arrived With Brepocitinib's Blockbuster Data (Rating Upgrade)
10:37pm, Friday, 06'th Feb 2026
Roivant: The Next Telavant Has Arrived With Brepocitinib's Blockbuster Data (Rating Upgrade)
Roivant Sciences Ltd. (ROIV) Q3 2025 Earnings Call Transcript
03:44pm, Friday, 06'th Feb 2026
Roivant Sciences Ltd. (ROIV) Q3 2025 Earnings Call Transcript
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates
09:15am, Friday, 06'th Feb 2026
Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.27.
BASEL, Switzerland and LONDON and NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced positive Phase 2 results for brepocitinib in cutaneous sarcoidosis (CS) and reporte
Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)
07:00am, Friday, 06'th Feb 2026
DURHAM, N.C., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Priovant Therapeutics today announced positive results from the Phase 2 BEACON study evaluating brepocitinib in cutaneous sarcoidosis (CS). CS is a high
WALTHAM, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Pulmovant, a clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases, and a Roivant (Nasdaq: ROIV
BASEL, Switzerland and LONDON and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, Feb
